A Phase 1 Single Centre Single-Blind Randomised Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD3355 After Administration of Single Ascending Doses and Multiple Repeated Doses in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 06 Dec 2010
At a glance
- Drugs Lesogaberan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions
- Sponsors AstraZeneca
- 06 Dec 2010 Actual end date changed from Jan 2009 to Dec 2008 as reported by ClinicalTrials.gov.
- 23 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2008 New trial record.